Home/Filings/4/0001039828-23-000149
4//SEC Filing

Lorenzen Jeffrey D 4

Accession 0001039828-23-000149

CIK 0001039828other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 6:54 PM ET

Size

18.9 KB

Accession

0001039828-23-000149

Insider Transaction Report

Form 4
Period: 2023-09-21
Lorenzen Jeffrey D
Sr. Vice President-Investments
Transactions
  • Sale

    Common Stock

    2023-09-21$53.85/sh76,619$4,125,58151,676 total
  • Exercise/Conversion

    Common Stock

    2023-09-21$27.05/sh+49,565$1,340,733128,295 total
  • Exercise/Conversion

    Options - Right to Buy

    2023-09-2111,2990 total
    Exercise: $31.63From: 2022-06-02Exp: 2031-06-02Common Stock (11,299 underlying)
  • Exercise/Conversion

    Options - Right to Buy

    2023-09-2149,5650 total
    Exercise: $27.05From: 2022-01-02Exp: 2030-11-19Common Stock (49,565 underlying)
  • Exercise/Conversion

    Common Stock

    2023-09-21$27.40/sh+15,755$431,68778,730 total
  • Exercise/Conversion

    Common Stock

    2023-09-21$31.63/sh+11,299$357,38762,975 total
  • Sale

    Common Stock

    2023-09-21$53.87/sh20,776$1,119,29030,900 total
  • Exercise/Conversion

    Options - Right to Buy

    2023-09-2115,7557,877 total
    Exercise: $27.40From: 2022-02-25Exp: 2031-02-25Common Stock (15,755 underlying)
Holdings
  • Common Stock

    (indirect: By ESOP)
    14,045
Footnotes (6)
  • [F1]This transaction was executed in multiple trades at prices ranging from $53.74 to $53.91. The price reported in column 4 is an average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold and the prices at which the transactions were settled.
  • [F2]This transaction was executed in multiple trades at prices ranging from $53.83 to $53.92. The price reported in column 4 is an average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold and the prices at which the transactions were settled.
  • [F3]Reflects ESOP allocations that have occurred since the date of the reporting person's last ownership report.
  • [F4]Fifty percent (50%) of the option award granted vested on June 2, 2022, upon the performance of certain company objectives. The remaining fifty percent (50%) of the option award vested on the one year anniversary of the vesting of the initial fifty percent (50%) of the option award.
  • [F5]An award of stock options pursuant to the American Equity Investment Life Holding Company Amended and Restated Equity Incentive Plan, 1/3 of which vest one year from date of grant; 1/3 vest two years from date of grant and 1/3 vest three years from date of grant. One-half of these options became exercisable on February 25, 2022, and the other half became exercisable on February 25, 2023.
  • [F6]Fifty percent (50%) of the option award granted vested on January 2, 2022, upon the performance of certain company objectives. The remaining fifty percent (50%) of the option award vested on the one year anniversary of the vesting of the initial fifty percent (50%) of the option award.

Issuer

AMERICAN EQUITY INVESTMENT LIFE HOLDING CO

CIK 0001039828

Entity typeother

Related Parties

1
  • filerCIK 0001353991

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 6:54 PM ET
Size
18.9 KB